Name: Latest research reports of Biocon Ltd. authored by Sharekhan and published by - Trendlyne research reports.
Item: Biocon Ltd.
Rating: 5
Author: Sharekhan

Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer

335.7000 1.90 (0.57%)

NSE Apr 23, 2025 15:31 PM

Volume: 2.7M

Biocon Ltd.

28 Jun 2024

335.70

0.57%

GLP product launch a big opportunity

Buy: Biocon Ltd.

Target

Sharekhan

Biocon recently signed an exclusive licensing and supply agreement with Handok, a South Korean specialty pharma company for commercialization of synthetic liraglutide.

Biocon Ltd. is trading above its 30 day SMA of 333.3